Insulin Glargine [aapp, horm, phsu]
glycemia [carb]
Insulin Resistance [patf]
Patients [podg]
Type 2 Diabetes [dsyn]
Exhibit [inpr]
High Risk [qlco]
Cardiovascular disease [dsyn]
Present [qnco]
Study [mnob]
Efficacy [qlco]
Safety [hcpp]
Administer [ftcn]
Insulin Glargine [aapp, horm, phsu]
Diabetes Mellitus, Type 2 [dsyn]
Patients [podg]
High Risk [qlco]
Cardiovascular disease [dsyn]
Assessed [acty]
Type 2 Diabetes [dsyn]
Patients [podg]
High Risk [qlco]
Cardiovascular disease [dsyn]
divided [ftcn]
Insulin Glargine [aapp, horm, phsu]
Group [idcn]
Standard [qlco]
Care [acty]
Group [idcn]
Patients [podg]
Insulin Glargine [aapp, horm, phsu]
Group [idcn]
Received [qlco]
Oral [spco]
Antidiabetic Agents [phsu]
glargine [aapp, horm, phsu]
Subcutaneous injection [ftcn]
Patients [podg]
Standard [qlco]
Care [acty]
Group [idcn]
Administered [ftcn]
Oral [spco]
Antidiabetic Agents [phsu]
diabetic [fndg]
treatment guidelines [topp]
Comparison [acty]
Make [ftcn]
Group [idcn]
Levels [qlco]
Plasma glucose [lbpr]
Glycosylated haemoglobin [aapp, bacs]
Plasma lipids [lbpr]
Homeostasis model assessment [lbpr]
insulin secretion [celf]
Index [inpr]
Beta [plnt]
Insulin Resistance [patf]
Index [inpr]
Hypoglycaemia [dsyn]
adverse events [fndg]
CARDIOVASCULAR [bdsy]
Body Mass Index [diap]
Fasting [fndg]
plasma glucose level [lbtr]
Insulin Glargine [aapp, horm, phsu]
Group [idcn]
Observed [ftcn]
Standard [qlco]
Care [acty]
Group [idcn]
Levels [qlco]
2 H [elii]
Postprandial [tmco]
Glucose [bacs, carb, phsu]
Plasma lipids [lbpr]
Body Mass Index [diap]
Group [idcn]
Beta [plnt]
Group [idcn]
Insulin Resistance [patf]
Index [inpr]
Insulin Glargine [aapp, horm, phsu]
Group [idcn]
Observed [ftcn]
Standard [qlco]
Care [acty]
Group [idcn]
Hypoglycaemia [dsyn]
Insulin Glargine [aapp, horm, phsu]
Group [idcn]
Compared [acty]
Standard [qlco]
Care [acty]
Group [idcn]
adverse events [fndg]
CARDIOVASCULAR [bdsy]
Observed [ftcn]
Present [qnco]
Study [mnob]
Indicated [fndg]
Insulin Glargine [aapp, horm, phsu]
glycemia [carb]
Insulin Resistance [patf]
Increasing [ftcn]
cardiovascular events [fndg]
Type 2 Diabetes [dsyn]
Patients [podg]
considered [idcn]
High Risk [qlco]
Cardiovascular disease [dsyn]
